Carregant...

Prostate Cancer: Update on Early Detection and New Biomarkers

Screening and early treatment of prostate cancer (PCa) has recently come under scrutiny due to the rates of overdiagnosis of low risk cancer. Randomized trials, including ERSPC and PLCO, have informed our understanding of the survival benefit provided by systematic PCa screening with serum prostate-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mo Med
Autor principal: Grubb, Robert L.
Format: Artigo
Idioma:Inglês
Publicat: Journal of the Missouri State Medical Association 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6139871/
https://ncbi.nlm.nih.gov/pubmed/30228704
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!